NuMedii

📍 San Mateo, United States🗓 Founded 2008👥 5 employees💰 Last funded Sep 2014
Biotechnology🌐 numedii.com
Website LinkedIn
NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2008
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Singapore
1
Investor activity2013–2014 · investors recorded per year
2013120142
Recent (last 2y)Earlier
Frequently asked questions
Who invested in NuMedii?
NuMedii has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did NuMedii last raise funding?
The most recent investment in NuMedii recorded on gritt.io was in September 2014.
When was NuMedii founded?
NuMedii was founded in 2008.
What industry is NuMedii in?
NuMedii operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NuMedii based?
NuMedii is headquartered in San Mateo, United States.